Stay updated on Dolutegravir for HIV Treatment Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir for HIV Treatment Clinical Trial page.

Latest updates to the Dolutegravir for HIV Treatment Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision label on the study page updated from v3.6.3 to v3.6.4, indicating a new build of the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page now displays a newer revision tag, updating from v3.6.0 to v3.6.3, indicating a maintenance version update.SummaryDifference0.0%

- Check50 days agoChange DetectedEnrollment status now shows recruitment is closed. The page also introduces new help/navigation sections (e.g., How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision marker to v3.6.0.SummaryDifference0.3%

- Check57 days agoChange DetectedThe page version updated from v3.5.4 to v3.5.5, indicating a small update to the page metadata rather than changes to the study data.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating a newer version of the page in the system. No user-visible content changes are indicated by this revision.SummaryDifference0.0%

- Check100 days agoChange DetectedA page software/interface revision indicator was updated from v3.5.2 to v3.5.3, without modifying the study’s displayed clinical information.SummaryDifference0.0%

Stay in the know with updates to Dolutegravir for HIV Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir for HIV Treatment Clinical Trial page.